Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2X7O

Crystal structure of TGFbRI complexed with an indolinone inhibitor

Summary for 2X7O
Entry DOI10.2210/pdb2x7o/pdb
Related1B6C 1IAS 1PY5 1RW8 1VJY 2WOT 2WOU
DescriptorTGF-BETA RECEPTOR TYPE I, (3Z)-N-ETHYL-N-METHYL-2-OXO-3-(PHENYL{[4-(PIPERIDIN-1-YLMETHYL)PHENYL]AMINO}METHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-6-CARBOXAMIDE (2 entities in total)
Functional Keywordskinase, transferase, glycoprotein
Biological sourceHOMO SAPIENS (HUMAN)
Total number of polymer chains5
Total formula weight197076.34
Authors
Roth, G.J.,Heckel, A.,Brandl, T.,Grauert, M.,Hoerer, S.,Kley, J.T.,Schnapp, G.,Baum, P.,Mennerich, D.,Schnapp, A.,Park, J.E. (deposition date: 2010-03-03, release date: 2010-10-20, Last modification date: 2023-12-20)
Primary citationRoth, G.J.,Heckel, A.,Brandl, T.,Grauert, M.,Hoerer, S.,Kley, J.T.,Schnapp, G.,Baum, P.,Mennerich, D.,Schnapp, A.,Park, J.E.
Design, Synthesis and Evaluation of Indolinones as Inhibitors of the Transforming Growth Factor Beta Receptor I (Tgfbri)
J.Med.Chem., 53:7287-, 2010
Cited by
PubMed Abstract: Inhibition of transforming growth factor β (TGFβ) type I receptor (Alk5) offers a novel approach for the treatment of fibrotic diseases and cancer. Indolinones substituted in position 6 were identified as a new chemotype inhibiting TGFβRI concomitant with a low cross-reactivity among the human kinome. A subset of compounds showed additional inhibition of platelet-derived growth factor receptor alpha (PDGFRα), contributing to an interesting pharmacological profile. In contrast, p38 kinase, which is often inhibited by TGFβRI inhibitors, was not targeted by derivatives based on the indolinone chemotype. Guided by an X-ray structure of lead compound 5 (BIBF0775) soaked into the kinase domain of TGFβRI, optimization furnished potent and selective inhibitors of TGFβRI. Potent inhibition translated well into good inhibition of TGFβRI-mediated phosphorylation of Smad2/3, demonstrating efficacy in a cellular setting. Optimized compounds were extensively profiled on a 232-kinase panel and showed low cross-reactivities within the human kinome.
PubMed: 20919678
DOI: 10.1021/JM100812A
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.7 Å)
Structure validation

238582

數據於2025-07-09公開中

PDB statisticsPDBj update infoContact PDBjnumon